BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32364630)

  • 1. Causes of hypereosinophilia in 100 consecutive patients.
    Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
    Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance.
    Helbig G; Hus M; Francuz T; Dziaczkowska-Suszek J; Soja A; Kyrcz-Krzemień S
    Med Oncol; 2014 Jan; 31(1):815. PubMed ID: 24338273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked and persistent eosinophilia in the absence of clinical manifestations.
    Chen YY; Khoury P; Ware JM; Holland-Thomas NC; Stoddard JL; Gurprasad S; Waldner AJ; Klion AD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1195-202. PubMed ID: 23987798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis].
    Holle JU; Moosig F
    Z Rheumatol; 2023 May; 82(4):307-320. PubMed ID: 37099180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.
    Carruthers MN; Park S; Slack GW; Dalal BI; Skinnider BF; Schaeffer DF; Dutz JP; Law JK; Donnellan F; Marquez V; Seidman M; Wong PC; Mattman A; Chen LY
    Eur J Haematol; 2017 Apr; 98(4):378-387. PubMed ID: 28005278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in diagnosis and treatment of eosinophilia.
    Sheikh J; Weller PF
    Curr Opin Hematol; 2009 Jan; 16(1):3-8. PubMed ID: 19057198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical approach to the patient with hypereosinophilia.
    Roufosse F; Weller PF
    J Allergy Clin Immunol; 2010 Jul; 126(1):39-44. PubMed ID: 20538328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2017 Nov; 92(11):1243-1259. PubMed ID: 29044676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypereosinophilic syndromes.
    Kahn JE; Blétry O; Guillevin L
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):863-82. PubMed ID: 19028368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and causes of hypereosinophilia (corrected) in the patients of a university hospital].
    Kim DW; Shin MG; Yun HK; Kim SH; Shin JH; Suh SP; Ryang DW
    Korean J Lab Med; 2009 Jun; 29(3):185-93. PubMed ID: 19571614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current differential diagnosis of hypereosinophilic syndrome].
    Dinić-Uzurov V; Lalosević V; Milosević I; Urosević I; Lalosević D; Popović S
    Med Pregl; 2007; 60(11-12):581-6. PubMed ID: 18666600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The causes of a peripheral blood eosinophilia in a secondary care setting.
    Wardlaw AJ; Wharin S; Aung H; Shaffu S; Siddiqui S
    Clin Exp Allergy; 2021 Jul; 51(7):902-914. PubMed ID: 34080735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
    Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
    Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of severe eosinophilia with uncertain aetiology and proposals on a practical approach to its management.
    Ang AL; Wong RX; Zhuang QY; Linn YC
    Intern Med J; 2012 Aug; 42(8):928-33. PubMed ID: 22151137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Lymphoid Variant of HES (L-HES) as Differential Diagnose of Severe Asthma in Childhood].
    Leu T; Rauthe S; Wirth C; Simon HU; Kunzmann V; Hebestreit H; Kunzmann S
    Klin Padiatr; 2016 Nov; 228(6-07):319-324. PubMed ID: 27846662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.